Trial Profile
An open label, multicentre study to evaluate the inhibitory antibody formation in patients with hereditary angioedema treated with C1-esterase inhibitor
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2016
Price :
$35
*
At a glance
- Drugs Complement C1 inhibitor protein (Primary)
- Indications Hereditary angioedema
- Focus Pharmacodynamics
- 18 Mar 2016 New trial record
- 07 Mar 2016 Results presented at the 2016 Annual Meeting of the American Academy of Allergy, Asthma and Immunology